SP140 inhibits STAT1 signaling, induces IFN-γ in tumor-associated macrophages, and is a predictive biomarker of immunotherapy response

Tanagala, K. K. K., Morin-Baxter, J., Carvajal, R., Cheema, M., Dubey, S., Nakagawa, H., Yoon, A., Cheng, Y.-S. L., Taylor, A., Nickerson, J., Mintz, A., & Momen-Heravi, F. (2022). SP140 inhibits STAT1 signaling, induces IFN-γ in tumor-associated macrophages, and is a predictive biomarker of immunotherapy response. Journal for ImmunoTherapy of Cancer, 10(12), e005088. https://doi.org/10.1136/jitc-2022-005088
Authors:
Kranthi Kiran Kishore Tanagala
Joshua Morin‐Baxter
Richard D. Carvajal
Maryum Cheema
Sunil Dubey
Hiroshi Nakagawa
Angela J. Yoon
Yi‐Shing Lisa Cheng
Alison M. Taylor
Jeffrey A. Nickerson
Akiva Mintz
Fatemeh Momen‐Heravi
Affiliated Authors:
Kranthi Kiran Kishore Tanagala
Joshua Morin‐Baxter
Richard D. Carvajal
Maryum Cheema
Sunil Dubey
Hiroshi Nakagawa
Alison M. Taylor
Akiva Mintz
Fatemeh Momen‐Heravi
Author Keywords:
head and neck neoplasms
biomarkers
tumor
immunotherapy
macrophages
biomarkers, tumor
Publication Type:
Article
Unique ID:
10.1136/jitc-2022-005088
PMID:
Publication Date:
Data Source:
OpenAlex

Record Created: